A Texas-sized verdict

The US drug company picked what looked an easy win for its first court defence of recalled painkiller Vioxx. It lost spectacularly. The verdict will be reduced. But the group s own goal may cost it billions.
The US drug company picked what looked an easy win for its first court defence of recalled painkiller Vioxx. It lost spectacularly. The verdict will be reduced. But the group s own goal may cost it billions.
Required fields *